Search - tctmd.com

Displaying 321 - 340 of 361

Sort: Relevancy | Date

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

Yael L. Maxwell

June 05, 2015

News Daily News

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

May 14, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

April 03, 2015

News Conference News ACC 2015

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

Todd Neale

March 14, 2015

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

January 29, 2015

News Daily News

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Yael L. Maxwell

January 12, 2015

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

News Daily News

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

July 24, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Conference News ACC 2014

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

April 02, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

Advertisement

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content